Enhanced tumor visualization by γ-scintigraphy with 111In-labeled polychelating-polymer-containing immunoliposomes

Molecular Pharmaceutics

Volumn 3, Issue 5, 2006, Pages 525-530

  Erdogan, Suna ^a   Roby, Aruna ^a   Torchilin, Vladimir P ^a  

^a NORTHEASTERN UNIVERSITY   (United States)

Author keywords

scintigraphy; 111In; Liposome; Monoclonal antibody 2C5; Polychelating amphiphilic polymer; Tumor imaging

Indexed keywords

CHELATING AGENT; IMMUNOLIPOSOME; INDIUM 111; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 2C5; POLYMER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CELL SURFACE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG FORMULATION; FEMALE; GAMMA SCINTIGRAPHY; LEWIS CARCINOMA; LIVER CANCER; LUNG CARCINOMA; MOLECULAR IMAGING; MOUSE; NONHUMAN; PRIORITY JOURNAL; WHOLE BODY RADIATION;

ANIMALS; ANTIBODIES, MONOCLONAL; CARCINOMA, LEWIS LUNG; CHELATING AGENTS; INDIUM RADIOISOTOPES; LIPOSOMES; MICE; POLYMERS; RADIONUCLIDE IMAGING; TIME FACTORS;

EID: 33750404842     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp060055t     Document Type: Article

References (23)

1. Wolf, G. L. Targeted delivery of imaging agents: An overview. In Handbook of targeted delivery of imaging agents; Torchilin, V. P., Ed.; CRC Press Inc.: Boca Raton, FL, 1995; pp 3-22.
2. Caride, V. J. Liposomes as carriers of imaging agents. Crit. Rev. Ther. Drug Carrier Syst. 1985, 1 (2), 121-153.
3. Seltzer, S. E. The role of liposomes in diagnostic imaging. Radiology 1989, 171 (1), 19-21.
4. Torchilin, V. P. Liposomes as delivery agents for medical imaging. Mol. Med. Today 1996, 2 (6), 242-249.
5. Phillips, W. T. Delivery of gamma-imaging agents by liposomes. Adv. Drug Delivery Rev. 1999, 37 (1-3), 13-32.
6. Tilcock, C. Delivery of contrast agents for magnetic resonance imaging, computed tomography, nuclear medicine and ultrasound. Adv. Drug Deliver Rev. 1999, 37 (1-3), 33-51.
7. Torchilin, V. P. Pharmacokinetic considerations in the development of labeled liposomes and micelles for diagnostic imaging. Q. J. Nucl. Med. 1997, 41 (2), 141-153.
8. Mulder, W. J.; Strijkers, G. J.; van Tilborg, G. A.; Griffioen, A. W.; Nicolay, K. Lipid-based nanoparticles for contrast-enhanced MRI and molecular imaging. NMR Biomed. 2006, 19 (1), 142-164.
9. Kabalka, G. W.; Davis, M. A.; Moss, T. H.; Buonocore, E.; Hubner, K.; Holmberg, E.; Maruyama, K.; Huang, L. Gadolinium-labeled liposomes containing various amphiphilic Gd-DTPA derivatives: targeted MRI contrast enhancement agents for the liver. Magn. Reson. Med. 1991, 19 (2), 406-415.
10. Harrington, K. J.; Rowlinson-Busza, G.; Syrigos, K. N.; Uster, P. S.; Abra, R. M.; Stewart, J. S. Biodistribution and pharmacokinetics of 111In-DTPA-labelled pegylated liposomes in a human tumour xenograft model: implications for novel targeting strategies. Br. J. Cancer 2000, 83 (2), 232-238.
11. Trubetskoy, V. S.; Torchilin, V. P. New approaches in the chemical design of Gd-containing liposomes for use in magnetic resonance imaging of lymph nodes. J. Lipid Res. 1994, 4, 961-980.
12. Weissig, V. V.; Babich, J.; Torchilin, V. P. Long-circulating gadolinium-loaded liposomes: potential use for magnetic resonance imaging of the blood pool. Colloids Surf., B: Biointerfaces 2000, 18 (3-4), 293-299.
13. Torchilin, V. P. Polymeric contrast agents for medical imaging. Curr. Pharm. Biotechnol. 2000, 1, 183-215.
14. Gupta, H.; Weissleder, R. Targeted contrast agents in MR imaging. Magn. Reson. Imaging Clin. N. Am. 1996, 4 (1), 171-184.
15. Harrington, K. J.; Mubashar, M.; Peters, A. M. Polyethylene glycol in the design of tumor-targetting radiolabelled macromolecules-lessons from liposomes and monoclonal antibodies. Q. J. Nucl. Med. 2002, 46 (3), 171-180.
16. Morawski, A. M.; Lanza, G. A.; Wickline, S. A. Targeted contrast agents for magnetic resonance imaging and ultrasound. Curr. Opin. Biotechnol. 2005, 16 (1), 89-92.
17. Iakoubov, L. Z.; Torchilin, V. P. A novel class of antitumor antibodies: nucleosome-restricted antinuclear autoantibodies (ANA) from healthy aged nonautoimmune mice. Oncol. Res. 1997, 9 (8), 439-446.
18. Iakoubov, L. Z.; Torchilin, V. P. Nucleosome-releasing treatment makes surviving tumor cells better targets for nucleosome-specific anticancer antibodies. Cancer Detect. Prev. 1998, 22 (5), 470-475.
19. Torchilin, V. P.; Lukyanov, A. N.; Gao, Z.; Papahadjopoulos-Sternberg, B. Immunomicelles: targeted pharmaceutical carriers for poorly soluble drugs. Proc. Natl. Acad. Sci. U.S.A. 2003, 100 (10), 6039-6044.
20. Lukyanov, A. N.; Elbayoumi, T. A.; Chakilam, A. R.; Torchilin, V. P. Tumor-targeted liposomes: doxorubicin-loaded long-circulating liposomes modified with anti-cancer antibody. J. Controlled Release 2004, 100 (1), 135-144.
21. Gupta, B.; Levchenko, T. S.; Mongayt, D. A.; Torchilin, V. P. Monoclonal antibody 2C5-mediated binding of liposomes to brain tumor cells in vitro and in subcutaneous tumor model in vivo. J. Drug Targeting 2005, 13 (6), 337-343.
22. Erdogan, S.; Aruna, R.; Sawant, R.; Hurley, J.; Torchilin, V. P. Gadolinium-loaded polychelating polymer-containing cancer cell-specific immunoliposomes. J. Lipid Res. 2006, 16, 45-55.
23. Torchilin, V. P.; Levchenko, T. S.; Lukyanov, A. N.; Khaw, B. A.; Klibanov, A. L.; Rammohan, R.; Samokhin, G. P.; Whiteman, K. R. p-Nitrophenylcarbonyl-PEG-PE-liposomes: fast and simple attachment of specific ligands, including monoclonal antibodies, to distal ends of PEG chains via p-nitrophenylcarbonyl groups. Biochim Biophys Acta 2001, 1511 (2), 397-411.